Alkermes Employee Directory
Biotechnology ResearchDublin, Ireland1001-5000 Employees
Alkermes is a biotechnology company focused on neuroscience, developing medicines for complex psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders. It combines patient-informed science with an integrated research strategy and development and commercial capabilities to advance therapies for chronic conditions that have historically been overlooked or stigmatized. The organization emphasizes its people and empathy for patients, families, and caregivers as a central strength shaping its culture. The company is headquartered in Dublin, Ireland, with a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. In June 2026, Alkermes announced positive results from the Vibrance-2 Phase 2 study of alixorexton in adults with narcolepsy type 2, reporting improvements on wakefulness and sleepiness measures. The company also announced orphan drug designations from the U.S. FDA and European authorities for alixorexton in the treatment of idiopathic hypersomnia and narcolepsy, reflecting regulatory recognition for its sleep-disorder program.
1-888-653-2347 
support@leadiq.com 
